Tuesday, November 10, 2026, 2:00 pm EST
This talk will highlight new findings from studies examining how personality disorder assessments, measures of cognitive functioning, and neuroimaging can characterize and predict suicidal ideation outcomes in high-risk psychiatric populations, including individuals with borderline personality disorder (BPD). Dr. Traynor will also discuss emerging brain-based treatments for suicidal ideation that target functioning in major neural networks implicated in cognitive control and emotion regulation.
Please use #BBRFWebinar when sharing or posting about our Meet the Scientist Webinars on social media.
Sign up for other upcoming webinars.
View past webinar recordings.
Presented by
Director, Dimensional Exploration of Self, Emotion, Risk and Treatment (DESERT) Lab
Clinician-Scientist and Staff Psychologist
2022 Young Investigator Grant
Dr. Traynor is a Clinician-Scientist and Staff Psychologist at McLean Hospital and Instructor in Psychology at Harvard Medical School. At McLean Hospital, she is the Director of the Dimensional Exploration of Self, Emotion, Risk and Treatment (DESERT) Lab, which focuses on developing new treatments for people with Borderline Personality Disorder and related conditions, and on building predictive models of suicide risk and treatment response using functional neuroimaging, cognitive, and symptom-level data. Dr. Traynor is also a registered clinical psychologist who specializes in treating personality and trauma-related disorders. She is the recipient of a 2022 Young Investigator Award from the BBRF and Families for BPD Research.
Moderated by
Brain & Behavior Research Foundation
Jeffrey Borenstein, M.D., serves as the President & CEO of the Brain & Behavior Research Foundation, the largest private funder of mental health research grants. Dr. Borenstein developed the Emmy-nominated public television program “Healthy Minds,” and serves as host and executive producer of the series. The program, broadcast nationwide, is available online, and focuses on topics in psychiatry in order to educate the public, reduce stigma and offer a message of hope. Dr. Borenstein served as Editor-in-Chief of Psychiatric News, the newspaper of the American Psychiatric Association from 2012 - 2023.
Dr. Borenstein is a Fellow of the New York Academy of Medicine and serves as the Chair of the Section of Psychiatry at the Academy. He also has served as the President of the New York State Psychiatric Association. Dr. Borenstein earned his undergraduate degree at Harvard and his medical degree at New York University.
